ProCE Banner Activity

Australian Perspectives on Advances in HIV

Podcast Episodes

This podcast episode features Australian perspectives on some of the most important HIV insights gained over the past year, including the latest in HIV treatment and prevention and key new advances in HIV cure research.

Released: February 17, 2023

Expiration: February 16, 2024

Share

Faculty

Sharon R. Lewin

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Director
Doherty Institute
Melbourne Laureate Professor and Head
Department of Infectious Diseases
The University of Melbourne
Consultant Physician
Victorian Infectious Diseases Service
Royal Melbourne Hospital
Consultant Physician and Adjunct Professor Department of Infectious Diseases
Alfred Hospital and Monash University
Melbourne, Australia

Don E Smith

Don E Smith, MD, FRCP (London) FAChSHM

Senior Staff Specialist
Conjoint Professor
School of Clinical Medicine
University of New South Wales
Albion Centre
Sydney, Australia

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Director
Doherty Institute
Melbourne Laureate Professor and Head
Department of Infectious Diseases
The University of Melbourne
Consultant Physician
Victorian Infectious Diseases Service
Royal Melbourne Hospital
Consultant Physician and Adjunct Professor Department of Infectious Diseases
Alfred Hospital and Monash University
Melbourne, Australia

Sharon Lewin, AO, FRACP, PhD, FAHMS: consultant/advisor/speaker: AbbVie, Esfan, Gilead Sciences, Immunocore, Merck, Vaxxinity; researcher: Abbott, Gilead Sciences, Merck; safety monitoring committee: Gilead Sciences.

Don E Smith, MD, FRCP (London) FAChSHM

Senior Staff Specialist
Conjoint Professor
School of Clinical Medicine
University of New South Wales
Albion Centre
Sydney, Australia

Don Smith, MD: consultant/advisor/speaker: Gilead Sciences, ViiV Healthcare; researcher: ViiV Healthcare.